Serotonin 5-HT1A receptor blockade enhances Ca 2+/calmodulin-dependent protein kinase II function and membrane expression of AMPA receptor subunits in the rat hippocampus: Implications for memory formation

Journal of Neurochemistry

Volumn 94, Issue 4, 2005, Pages 884-895

  Schiapparelli, Lucio ^a   Del Río, Joaquín ^a   Frechilla, Diana ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

5 HT1A receptors; AMPA receptors; Ca2+ calmodulin dependent protein kinase II; Hippocampus; Memory; Serotonin

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; AMPA RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; FENCLONINE; GLUTAMATE RECEPTOR 1; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SEROTONIN 5A RECEPTOR; SEROTONIN ANTAGONIST; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; MEMORY; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANIMALS; AVOIDANCE LEARNING; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL MEMBRANE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HIPPOCAMPUS; MALE; MEMORY; PHOSPHOPROTEIN PHOSPHATASE; PIPERAZINES; PROTEIN ISOFORMS; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, AMPA; SEROTONIN ANTAGONISTS;

EID: 23844519572     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03193.x     Document Type: Article

References (66)

1. Allen P. B., Hvalby O., Jensen V. et al. (2000) Protein phosphatase-1 regulation in the induction of long-term potentiation: heterogeneous molecular mechanisms. J. Neurosci. 20, 3537-3543.
2. 3 receptor antagonist with anxiolytic-like properties in animal models. Psychopharmacology 117, 137-148.
3. Banke T. G., Bowie D., Lee H., Huganir R. L., Schousboe A. and Traynelis S. F. (2000) Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J. Neurosci. 20, 89-102.
4. Barria A., Muller D., Derkach V., Griffith L. C. and Soderling T. R. (1997) Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 276, 2042-2045.
5. Bayer K.-U., Koninck P. D., Leonard A. S., Hell J. W. and Schulman H. (2001) Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature 411, 801-805.
6. Bliss T. V. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
7. Boast C., Bartolomeo A. A., Morris H. and Moyer J. A. (1999) 5-HT antagonists attenuate MK801-impaired radial arm maze performance in rats. Neurobiol. Learn. Mem. 71, 259-271.
8. Buhot M.-C. (1997) Serotonin receptors in cognitive behaviors. Curr. Opin. Neurobiol. 7, 243-254.
9. 2+/calmodulin-dependent protein kinase II activity in prefrontal cortical pyramidal neurons. J. Biol. Chem. 277, 36 553-36 562.
10. Calabresi P., Gubellini P., Centonze D., Picconi B., Bernardi G., Chergui K., Svenningsson P., Fienberg A. A. and Greengard P. (2000) Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J. Neurosci. 20, 8443-8451.
11. 2+/calmodulin-dependent protein kinase II activity and AMPA GluR1 subunit immunoreactivity. Eur. J. Neurosci. 10, 2669-2676.
12. 1A receptors. Br. J. Pharmacol. 105, 720-726.
13. 1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. Brain Res. 774, 167-174.
14. 1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors. Neuropharmacology 38, 1165-1173.
15. Corradetti R., Ballerini L., Pugliese A. M. and Pepeu G. (1992) Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience 46, 511-518.
16. 2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate type glutamate receptors. Proc. Natl Acad. Sci. USA 96, 3269-3274.
17. 1A antagonist. Br. J. Pharmacol. 115, 1169-1174.
18. Dunah A. W., Wang Y., Yasuda R. P., Kameyama K., Huganir R. L., Wolfe B. B. and Standaert D. G. (2000) Alterations in subunit expression, composition and phosphorylation of striatal N-Methyl-D-Aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol. Pharmacol 57, 342-352.
19. 1A receptor-mediated inhibition of long-term potentiation in rat visual cortex. Eur. J. Pharmacol. 349, 221-224.
20. 1A receptor selectively suppresses NMDA receptor-mediated synaptic excitation in the rat visual cortex. Brain Res. 827, 225-228.
21. 4 receptors. Trends Pharmacol. Sci. 16, 391-398.
22. Elgersma Y. and Silva A. J. (1999) Molecular mechanisms of synaptic plasticity and memory. Curr. Opin. Neurobiol. 9, 209-213.
23. Endo S., Zhou X., Connor J., Wang B. and Shenolikar S. (1996) Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor. Biochemistry 35, 5220-5228.
24. Fink C. C. and Meyer T. (2002) Molecular mechanisms of CaMKII activation in neuronal plasticity. Curr. Opin. Neurobiol. 12, 293-299.
25. 1A receptor antagonist. Behav. Brain Res. 73, 337-353.
26. 1A receptor antagonist, WAY100635. Eur. J. Pharmacol. 281, 81-88.
27. Genoux D., Haditsch U., Knobloch M., Michalon A., Storm D. and Mansuy I. M. (2002) Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418, 970-975.
28. 1B receptors with WAY 100,635 and GR 127,935. J. Neurochem. 68, 1159-1163.
29. 1A receptor antagonists NAN-190 and BMY7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur. J. Pharmacol. 211, 211-219.
30. 1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology 127, 245-254.
31. 1A receptors: behavioural and in vivo microdialysis studies. Life Sci. 46, 955-963.
32. Izquierdo I. and Medina J. H. (1997) Memory formation: The sequence of biochemical events in the hippocampus and its connection to activity in other brain regions. Neurobiol. Learn. Mem. 68, 285-316.
33. Jequier E., Lovenberg W. and Sjoerdsma A. (1967) Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Mol. Pharmacol. 3, 274-278.
34. 1A receptors in quiet awake rats: in vivo electrophysiological evidence. Neuropsychopharmacology 24, 141-151.
35. Kim C.-H., Chung H. J., Lee H.-K. and Huganir R. L. (2001) Interaction of the AMPA receptor subunit GluR2/3 with PDZ domains regulates hippocampal long-term depression. Proc. Natl Acad. Sci. USA 98, 11 725-11 730.
36. Lai M. K., Tsang S. W., Francis P. T., Keene J., Hope T., Esiri M. M., Spence I. and Chen C. P. (2002) Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease. Neuroreport 13, 1175-1178.
37. Lee H.-K., Takamiya K., Han J.-S. et al. (2003) Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory. Cell 112, 631-643.
38. Leonard A. S. and Hell J. W. (1997) Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites. J. Biol. Chem. 272, 12 107-12 115.
39. Lynch G. (2004) AMPA receptor modulators as cognitive enhancers. Curr. Opin. Pharmacol. 4, 4-11.
40. Malenka R. C. (2003) The long-term potential of LTP. Nat. Rev. Neurosci. 4, 923-926.
41. 4 receptor agonists and antagonists on rat learning and memory. Neuropharmacology 39, 2017-2027.
42. Mazer C., Muneyyirci J., Taheny K., Raio N., Borella A. and Whitaker-Azmitia P. (1997) Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 760, 68-73.
43. 1A receptor agonists induce anterograde amnesia in mice through a postsynaptic mechanism. Eur. J. Pharmacol. 236, 177-182.
44. Meng Y., Zhang Y. and Jia Z. (2003) Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3. Neuron 39, 163-176.
45. 1A receptor mRNA in rat forebrain and cerebellum. Dev. Brain Res. 80, 149-157.
46. Misane I. and Ögren S. O. (2000) Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Neuropsychopharmacology 22, 168-190.
47. 1A receptor involvement in passive avoidance in the rat. Br. J. Pharmacol. 125, 499-509.
48. 1A receptor-mediated learning deficit in rats. Neuropsychopharmacology 29, 2216-2224.
49. Moyano S., Frechilla D. and Del Río J. (2004b) NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment. Psychopharmacology 173, 337-345.
50. Nayak A., Zastrow D. J., Lickteig R., Zahniser N. R. and Browning M. D. (1998) Maintenance of late-phase LTP is accompanied by PKA-dependent increase in AMPA receptor synthesis. Nature 394, 680-683.
51. 1A receptors. Br. J. Pharmacol. 128, 1691-1698.
52. Pazos A. and Palacios J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346, 205-230.
53. Pérez-Otaño I., Herrero M. T., Oset C., De Ceballos M. L., Luquin M. R., Obeso J. A. and Del Río J. (1991) Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset. Brain Res. 567, 127-132.
54. 1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task. Brain Res. 983, 215-222.
55. Reisel D., Bannerman D. M., Schmitt W. B., Deacon R. M., Flint J., Borchardt T., Seeburg P. H. and Rawlins J. N. (2002) Spatial memory dissociations in mice lacking GluR1. Nat. Neurosci. 5, 868-873.
56. Roche K. W., O'Brien R. J., Mammen A. L., Bernhardt J. and Huganir R. L. (1996) Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16, 1179-1188.
57. 1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer's disease. Curr. Pharm. Des. 8, 139-145.
58. Schmitt W. B., Arianpour R., Deacon R. M., Seeburg P. H., Sprengel R., Rawlins J. N. and Bannerman D. M. (2004) The role of hippocampal glutamate receptor-A-dependent synaptic plasticity in conditional learning: the importance of spatiotemporal discontiguity. J. Neurosci. 24, 9277-9282.
59. 1A receptor blockade is not associated with increased activity of the central nucleus of the amygdala. Learn. Mem. 10, 394-400.
60. 1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br. J. Pharmacol. 95, 975-985.
61. Shen K. and Meyer T. (1999) Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science 284, 162-166.
62. Shi S. H., Hayashi Y., Esteban J. A. and Malinow R. (2001) Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell 105, 331-334.
63. Shobe J. (2002) The role of PKA, CaMKII, and PKC in avoidance conditioning: permissive or instructive? Neurobiol. Learn. Mem. 77, 291-312.
64. Soderling T. R. and Derkach V. A. (2000) Postsynaptic protein phosphorylation and LTP. Trends Neurosci. 23, 75-80.
65. Yasuno F., Suhara T., Nakayama T., Ichimiya T., Okubo Y., Takano A., Ando T., Inoue M., Maeda J. and Suzuki K. (2003) Inhibitory effect of hippocampal 5-HT(1A) receptors on human explicit memory. Am. J. Psychiatry 160, 334-340.
66. Zhao D., Watson J. B. and Xie C.-W. (2004) Amyloid β prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation. J. Neurophysiol. 92, 2853-2858.